CXCR4 also sustains non-pharmacological resistance of tumor cells, through its effects on the stromal microenvironment that supplies growth- and drug-resistance signals to tumor cells (Burger and Kipps, 2006). The gene discussed is CXCR4; the disease is neoplasm.